We are live on ! Find out more
BGMS

Bio Green Med Solution Inc

9 hedge funds and large institutions have $200K invested in Bio Green Med Solution Inc in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

0.02% less ownership

Funds ownership: 0.07%0.04% (-0.02%)

10% less funds holding

Funds holding: 109 (-1)

46% less capital invested

Capital invested by funds: $371K → $200K (-$171K)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
9
Holders Change
-1
Holders Change %
-10%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change

BGMS Hedge Fund Activity: Q3 2024 in Review

9 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc (BGMS) for Q3 2024, worth a combined $200K — down 46% from $371K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of BGMS and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.

The largest buyer was Armistice Capital, adding an estimated $14.8K. The largest seller was UBS Group, cutting an estimated $34.2K.

  • 9 institutional investors held Bio Green Med Solution Inc (BGMS) as of Q3 2024, down from 10 in Q2 2024.
  • Funds reported $200K of Bio Green Med Solution Inc stock for Q3 2024, down 46% quarter-over-quarter.
  • 1 fund opened new Bio Green Med Solution Inc positions in Q3 2024 and 2 closed out, a net change of -1 holder.
  • The largest Bio Green Med Solution Inc buyer in Q3 2024 was Armistice Capital, an estimated $14.8K added.
  • The largest Bio Green Med Solution Inc seller in Q3 2024 was UBS Group, an estimated $34.2K sold.

Based on aggregated 13F filings for Q3 2024.